Next Article in Journal
DNA Damage: A Main Determinant of Vascular Aging
Next Article in Special Issue
Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules
Previous Article in Journal
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis
Previous Article in Special Issue
Autophagy, Innate Immunity and Tissue Repair in Acute Kidney Injury
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2016, 17(5), 751;

Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis

Department of Pharmacology & Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Department of Entomology & Cancer Center, University of California, Davis, CA 95616, USA
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Academic Editor: Alan Parrish
Received: 12 April 2016 / Revised: 5 May 2016 / Accepted: 9 May 2016 / Published: 18 May 2016
(This article belongs to the Special Issue Advances in Chronic Kidney Disease)
Full-Text   |   PDF [3351 KB, uploaded 18 May 2016]   |  


Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs) that have multiple biological actions. The present study determined the ability of the most abundant EDP regioisomer, 19,20-EDP to reduce kidney injury in an experimental unilateral ureteral obstruction (UUO) renal fibrosis mouse model. Mice with UUO developed kidney tubular injury and interstitial fibrosis. UUO mice had elevated kidney hydroxyproline content and five-times greater collagen positive fibrotic area than sham control mice. 19,20-EDP treatment to UUO mice for 10 days reduced renal fibrosis with a 40%–50% reduction in collagen positive area and hydroxyproline content. There was a six-fold increase in kidney α-smooth muscle actin (α-SMA) positive area in UUO mice compared to sham control mice, and 19,20-EDP treatment to UUO mice decreased α-SMA immunopositive area by 60%. UUO mice demonstrated renal epithelial-to-mesenchymal transition (EMT) with reduced expression of the epithelial marker E-cadherin and elevated expression of multiple mesenchymal markers (FSP-1, α-SMA, and desmin). Interestingly, 19,20-EDP treatment reduced renal EMT in UUO by decreasing mesenchymal and increasing epithelial marker expression. Overall, we demonstrate that a novel omega-3 fatty acid metabolite 19,20-EDP, prevents UUO-induced renal fibrosis in mice by reducing renal EMT. View Full-Text
Keywords: omega-3 fatty acid; fatty acid epoxide; renal fibrosis; epithelial-to-mesenchymal transition omega-3 fatty acid; fatty acid epoxide; renal fibrosis; epithelial-to-mesenchymal transition

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Sharma, A.; Khan, M.A.H.; Levick, S.P.; Lee, K.S.S.; Hammock, B.D.; Imig, J.D. Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis. Int. J. Mol. Sci. 2016, 17, 751.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top